CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 409 filers reported holding CRISPR THERAPEUTICS AG in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,121,367 | -19.1% | 90,799 | +0.1% | 0.00% | -25.0% |
| Q2 2023 | $5,094,873 | +37.9% | 90,753 | +11.1% | 0.00% | +33.3% |
| Q1 2023 | $3,695,879 | +16.7% | 81,713 | +4.9% | 0.00% | 0.0% |
| Q4 2022 | $3,166,025 | -38.0% | 77,885 | -0.4% | 0.00% | -40.0% |
| Q3 2022 | $5,108,000 | +16.7% | 78,159 | +8.5% | 0.01% | +25.0% |
| Q2 2022 | $4,377,000 | +6.7% | 72,019 | +10.2% | 0.00% | 0.0% |
| Q1 2022 | $4,103,000 | +3.8% | 65,372 | +25.4% | 0.00% | +33.3% |
| Q4 2021 | $3,951,000 | -36.3% | 52,132 | -5.9% | 0.00% | -50.0% |
| Q3 2021 | $6,203,000 | -22.8% | 55,418 | +11.7% | 0.01% | -25.0% |
| Q2 2021 | $8,035,000 | +42.4% | 49,630 | +7.2% | 0.01% | +33.3% |
| Q1 2021 | $5,642,000 | -34.8% | 46,306 | -18.1% | 0.01% | -45.5% |
| Q4 2020 | $8,656,000 | +182.0% | 56,532 | +54.1% | 0.01% | +120.0% |
| Q3 2020 | $3,069,000 | -27.2% | 36,692 | -36.0% | 0.01% | -28.6% |
| Q2 2020 | $4,213,000 | +347.7% | 57,328 | +158.3% | 0.01% | +250.0% |
| Q1 2020 | $941,000 | -18.0% | 22,197 | +17.9% | 0.00% | 0.0% |
| Q4 2019 | $1,147,000 | +113.6% | 18,834 | +43.7% | 0.00% | +100.0% |
| Q3 2019 | $537,000 | -65.8% | 13,105 | -60.6% | 0.00% | -66.7% |
| Q2 2019 | $1,568,000 | +431.5% | 33,298 | +303.6% | 0.00% | +200.0% |
| Q1 2019 | $295,000 | +5.4% | 8,251 | -15.9% | 0.00% | 0.0% |
| Q4 2018 | $280,000 | -20.0% | 9,809 | +24.4% | 0.00% | 0.0% |
| Q3 2018 | $350,000 | -11.6% | 7,885 | +16.9% | 0.00% | 0.0% |
| Q2 2018 | $396,000 | +54.7% | 6,747 | +20.3% | 0.00% | 0.0% |
| Q1 2018 | $256,000 | – | 5,610 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
| NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
| Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
| ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
| NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
| Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
| Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
| Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
| Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |